382 / 1708
POG
•
78 pts randomized to 35 Gy CSRT + 54 Gy PFRT +/-
MOPP
•
Borderline difference in 5-year survival, favoring
chemotherapy, 74% vs. 56%, (p = 0.06)
•
Pts > 5 yrs old, females and non-whites had the most
benefit
Krischer JP et al. J Neurosurg 1991; 74:905-9